Valuation Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. Other stock markets 08/07/2026			5-day change	1st Jan Change
10.34 ^CNY	-0.67%		-0.67%	-14.90%

22/05	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
19/05	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,999	4,552	4,186	4,133	3,195	4,069
Change	-	51.79%	-8.03%	-1.28%	-22.69%	27.36%
Enterprise Value (EV) ¹	2,772	4,588	4,433	4,491	3,489	4,345
Change	-	65.48%	-3.37%	1.31%	-22.32%	24.54%
P/E	21.8x	32.2x	26.9x	61.7x	79.5x	-63.9x
PBR	2.89x	4.09x	3.5x	3.5x	2.77x	3.92x
PEG	-	11.9x	2.4x	-1.1x	-2x	0x
Capitalization / Revenue	2.39x	3.83x	3.05x	3.2x	2.7x	3.46x
EV / Revenue	2.21x	3.86x	3.23x	3.48x	2.95x	3.69x
EV / EBITDA	15.6x	23.1x	18.8x	24.5x	20.1x	37.9x
EV / EBIT	21.8x	33.1x	26.7x	62.1x	88.3x	-164x
EV / FCF	-24.5x	-22.2x	-34.3x	-33.4x	27.7x	39.5x
FCF Yield	-4.07%	-4.51%	-2.92%	-2.99%	3.61%	2.53%
Dividend per Share ²	0.2198	0.2198	0.25	0.2	0.15	-
Rate of return	2.48%	1.63%	2%	1.62%	1.57%	-
EPS ²	0.4066	0.4176	0.4643	0.2	0.12	-0.19
Distribution rate	54.1%	52.6%	53.8%	100%	125%	-
Net sales ¹	1,253	1,190	1,372	1,292	1,182	1,176
EBITDA ¹	177.3	198.4	235.5	183.2	173.3	114.6
EBIT ¹	127.3	138.5	166	72.31	39.52	-26.57
Net income ¹	135.9	139.8	155.5	66.9	39.88	-63.47
Net Debt ¹	-226.3	36.22	247.3	358.9	294	276.1
Reference price ²	8.86	13.47	12.50	12.34	9.54	12.15
Nbr of stocks (in thousands)	3,38,359	3,37,992	3,34,893	3,34,893	3,34,893	3,34,893
Announcement Date	22/04/21	18/04/22	27/04/23	27/04/24	28/04/25	27/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.	-	-	-	-	51Cr
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,08400Cr
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	63TCr
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	45TCr
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	33TCr
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	30TCr
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	28TCr
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	22TCr
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	20TCr
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	17TCr
Average	16.38x	6.59x	16.89x	2.39%	36.6TCr
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%